Reversible central adrenal insufficiency in survivors of COVID-19: results from a 24-month longitudinal study.
Saroj Kumar SahooJayakrishnan C MenonNidhi TripathyMonalisa NayakSubhash YadavPublished in: Endocrine connections (2024)
Central AI was common during acute COVID-19 and at 12 months of follow-up. AI can be late onset, developing after recovery from COVID-19, and was transient in nature.